Patent: 4,450,103
✉ Email this page to a colleague
Summary for Patent: 4,450,103
Title: | Process for recovering human IFN-.beta. from a transformed microorganism |
Abstract: | A process for recovering IFN-.beta. from transformed bacteria comprising: disrupting the cell membranes of the bacteria; solubilizing the IFN-.beta. from the disruptate into an aqueous medium with a solubilizing agent such as sodium dodecyl sulfate; extracting the IFN-.beta. from the aqueous medium with 2-butanol, 2-methyl-butanol, or mixtures thereof under conditions that maintain phase separation between the aqueous meduim and the extractant; and isolating the IFN-.beta. from the extractant such as by precipitating the IFN-.beta. from an aqeous buffer mixture of the extractant by lowering the pH thereof. |
Inventor(s): | Konrad; Michael W. (Alameda, CA), Lin; Leo S. (Fremont, CA) |
Assignee: | Cetus Corporation (Emeryville, CA) |
Application Number: | 06/353,360 |
Patent Claims: | see list of patent claims |
Details for Patent 4,450,103
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | July 23, 1993 | ⤷ Sign Up | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 4,450,103
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 20090 | ⤷ Sign Up |
Australia | 1331783 | ⤷ Sign Up |
Australia | 549721 | ⤷ Sign Up |
Canada | 1187013 | ⤷ Sign Up |
Germany | 3363647 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |